Regulation - Merck & Co, Gastro-intestinals

Filter

Popular Filters

Merck & Co gets positive CHMP opinion for Remicade in new indication

22-01-2012

US drug giant Merck & Co (NYSE: MRK) says that announced that the European Medicines Agency’s Committee…

EuropeGastro-intestinalsMerck & CoPharmaceuticalRegulationRemicade

Regulatory briefs: Allergic reactions warning on Merck & Co’s Saphris; Eisai drops Pariet ER development

02-09-2011

The US Food and Drug Administration is warning that serious allergic reactions have been reported with…

EisaiGastro-intestinalsMerck & CoNeurologicalNorth AmericaParietPharmaceuticalRegulationSaphris

Back to top